Skip to main content
S. 2454 118th Congress Senate

Pharmaceutical Supply Chain Security Act

Official title: A bill to require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the People's Republic of China for finished pharma… Show full official titleShow less

Official title: A bill to require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the People's Republic of China for finished pharmaceutical products and active pharmaceutical ingredients.

Introduced: December 16, 2024 Introduced by: James Lankford Republican · Oklahoma See on congress.gov
Health
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 20, 2023
Read twice and referred to the Committee on Foreign Relations.
Jul 20, 2023
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 20, 2023

Read twice and referred to the Committee on Foreign Relations.

 Plain-English summary Congressional Research Service

Pharmaceutical Supply Chain Security Act

This bill directs certain agencies to report on and reduce the role of China in pharmaceutical supply chains.

Specifically, the Food and Drug Administration must report on pharmaceutical products and ingredients for which China supplies more than 20% of the quantities available in the United States. In addition, the President must develop a strategy to address the role of China in the global pharmaceutical supply chain and related threats to national security. The United States International Development Finance Corporation must also support manufacturing projects that promote the security of pharmaceutical supply chains, reduce reliance on China, and foster cooperation with other countries.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Peters, Gary C.
Michigan · Dec 16, 2024
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2454: Pharmaceutical Supply Chain Security Act. 118th Congress. Open America. https://openamerica.io/bill/118-S-2454/
MLA
"S. 2454: Pharmaceutical Supply Chain Security Act." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-S-2454/.
Bluebook (legal)
S. 2454, 118th Cong. (2026), https://openamerica.io/bill/118-S-2454/.
Markdown link
[S. 2454: Pharmaceutical Supply Chain Security Act](https://openamerica.io/bill/118-S-2454/)
Report a problem